Skip to main content
Print Save

A514 (Divalproex Sodium Delayed Release 500 mg)

Pill with imprint A514 is Yellow, Elliptical / Oval and has been identified as Divalproex Sodium Delayed Release 500 mg. It is supplied by Anchen Pharmaceuticals, Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A514

Divalproex Sodium Delayed Release

Imprint
A514
Strength
500 mg
Color
Yellow
Size
19.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Anchen Pharmaceuticals, Inc.
National Drug Code (NDC)
24979-0514
Inactive Ingredients
silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone, magnesium silicate, titanium dioxide, triethyl citrate, FD&C Yellow No. 5, ferric oxide red, cellacefate

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related Images for "A514"

Edarbi 40 mg ASL 40
Edarbi
Dallergy PSE 4 mg / 1.25 mg / 60 mg LAS 146
Dallergy PSE

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer